Kenvue Inc.
KVUE Consumer Defensive Household & Personal Products
Kenvue Inc.’s revenue for fiscal 2025 (year ended December 2025) was $15.1 billion, down 2.14% from fiscal 2024. In the quarter to June 2026, revenue grew 3.02%, EPS grew 9.09%, free cash flow grew 17.1% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years; insiders bought in the last twelve months.
Follow KVUE
Kenvue Inc. (KVUE) Revenue
Kenvue Inc.'s revenue for fiscal 2025 was $15.1B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $15.4B. Over the past ten years it has ranged from $14.3B (fiscal 2019) to $15.5B (fiscal 2024); the current reading is higher than 71% of that period. Kenvue Inc. ranks 5th of 28 Household & Personal Products companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $15.1B | (2.14%) |
| FY2024 | $15.5B | 0.07% |
| FY2023 | $15.4B | 3.30% |
| FY2022 | $15.0B | (0.69%) |
| FY2021 | $15.1B | 4.06% |
| FY2020 | $14.5B | 1.00% |
| FY2019 | $14.3B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $4.0B | 1.18% |
| Mar 2026 | $3.9B | 3.41% |
| Dec 2025 | $3.8B | 0.43% |
| Sep 2025 | $3.8B | (1.95%) |
| 14 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| UL Unilever PLC compare | $126.2B |
| CL Colgate-Palmolive Company compare | $21.0B |
| KMB Kimberly-Clark Corporation compare | $16.6B |
| KVUE Kenvue Inc. | $15.4B |
| EL The Estee Lauder Companies Inc. compare | $15.0B |
| CLX The Clorox Company compare | $6.7B |
| CHD Church & Dwight Co., Inc. compare | $6.2B |
| ELF e.l.f. Beauty compare | $1.8B |
| IPAR Interparfums, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on KVUE
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement